Regal Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,397
| Closed | -$227K | – | 609 |
|
|
2024
Q1 | $227K | Buy |
+2,397
| New | +$227K | 0.02% | 523 |
|
|
2021
Q1 | – | Sell |
-2,250
| Closed | -$317K | – | 439 |
|
|
2020
Q4 | $317K | Buy |
+2,250
| New | +$317K | 0.04% | 350 |
|
|
2020
Q3 | – | Sell |
-2,205
| Closed | -$247K | – | 307 |
|
|
2020
Q2 | $247K | Buy |
+2,205
| New | +$247K | 0.05% | 269 |
|
|
2016
Q1 | – | Sell |
-6,265
| Closed | -$439K | – | 287 |
|
|
2015
Q4 | $439K | Buy |
6,265
+2,321
| +59% | +$163K | 0.11% | 162 |
|
|
2015
Q3 | $245K | Buy |
3,944
+860
| +28% | +$53.4K | 0.06% | 210 |
|
|
2015
Q2 | $259K | Buy |
3,084
+3,009
| +4,012% | +$253K | 0.07% | 212 |
|
|
2015
Q1 | $6K | Buy |
+75
| New | +$6K | ﹤0.01% | 789 |
|